Sensitization of human colon adenocarcinoma cells (LoVo) to reactive oxygen species by a lysosomotropic compound

International Journal of Oncology

Volumn 29, Issue 4, 2006, Pages 947-955

  Agostinelli, Enzo ^a   Vedova, Laura Dalla ^a   Belli, Francesca ^a   Condello, Maria ^a   Arancia, Giuseppe ^b   Seiler, Nikolaus ^c  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^c IRCAD   (France)

Author keywords

Bovine serum amine oxidase; Colon adenocarcinoma cells; MDL 72527; Multidrug resistance; Polyamines

Indexed keywords

ALDEHYDE; AMINE OXIDASE (COPPER CONTAINING); ANTINEOPLASTIC AGENT; DRUG DERIVATIVE; HYDROGEN PEROXIDE; N,N' BIS(2,3 BUTADIENYL)PUTRESCINE; PUTRESCINE; REACTIVE OXYGEN METABOLITE; SPERMINE;

ADENOCARCINOMA; ANIMAL; ARTICLE; CATTLE; CELL CULTURE; CELL SURVIVAL; COLON TUMOR; DRUG EFFECT; DRUG RESISTANCE; ENZYMOLOGY; HUMAN; LYSOSOME; METABOLISM; ULTRASTRUCTURE;

ADENOCARCINOMA; ALDEHYDES; AMINE OXIDASE (COPPER-CONTAINING); ANIMALS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CATTLE; CELL SURVIVAL; COLONIC NEOPLASMS; DRUG RESISTANCE, NEOPLASM; HUMANS; HYDROGEN PEROXIDE; LYSOSOMES; PUTRESCINE; REACTIVE OXYGEN SPECIES; SPERMINE; TUMOR CELLS, CULTURED;

EID: 33749044114     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.29.4.947     Document Type: Article

References (31)

1. Cohen SS: A guide to the Polyamines. Oxford University Press, New York, Oxford, 1998.
2. Seiler N and Raul F: Polyamines and apoptosis. J Cell Mol Med 9: 623-642, 2005.
3. Calcabrini A, Arancia G, Marra M, Crateri P, Befani O, Martone A and Agostinelli E: Enzymatic oxidation products of spermine induce greater cytotoxic effects on human multidrug-resistant colon carcinoma cells (LoVo) than on their wild-type counterparts. Int J Cancer 93: 43-52, 2002.
4. Averill-Bates DA, Cherif A, Agostinelli E, Tanel A and Fortier G: Anti-tumoral effect of native and immobilized bovine serum amine oxidase in a mouse melanoma model. Biochem Pharmacol 69: 1693-1704, 2005. (Pubitemid 40780069)
5. Yoshikawa T, Kokura S, Tainaka K, Naito Y and Kondo M: A novel cancer therapy based on oxygen radicals. Cancer Res 55: 1617-1620, 1995.
6. Grandi M, Geroni C and Giuciani FC: Isolation and characterization of the human colon adenocarcinoma cell line resistant to doxorubicin. Br J Cancer 54: 515-518, 1986. (Pubitemid 16031557)
7. Arancia G, Calcabrini A, Marra M, Crateri P, Artico M, Martone A, Martelli F and Agostinelli E: Mitochondrial alterations induced by serum amine oxidase and spermine on human multidrug resistant tumor cells. Amino Acids 26: 273-282, 2004. (Pubitemid 38829791)
8. Droege W: Free radicals in the physiological control of cell function. Physiol Rev 82: 47-96, 2002.
9. Averill-Bates DA, Agostinelli E, Przybytkowski E, Mateescu MA and Mondovi B: Cytotoxicity and kinetic analysis of purified bovine serum amine oxidase in the presence of spermine in Chinese hamster ovary cells. Arch Biochem Biophys 300: 75-79, 1993. (Pubitemid 23225720)
10. Seiler N, Duranton B and Raul F: The polyamine oxidase inactivator MDL 72527. Prog Drug Res 59: 1-40, 2002.
11. Dai H, Kramer DL, Yang C, Murti KG, Porter CW and Cleveland JL: The polyamine oxidase inactivator MDL-72,527 selectively induces apoptosis in transformed hematopoietic cells through lysosomotropic effects. Cancer Res 59: 4944-4955, 1999.
12. Turini P, Sabatini S, Befani O, Chimenti F, Casanova C, Riccio P and Mondovi B: Purification of serum amine oxidase. Anal Biochem 125: 294-298, 1982.
13. Bey P, Bolkenius FN, Seiler N and Casara P: N-2,3-Butadienyl-1,4- butanediamine derivatives: Potent irreversible inhibitors of mammalian polyamine oxidase. J Med Chem 28: 1-2, 1985.
14. Dolfini E, Dasdia T, Arancia G, Molinari A, Calcabrini A, Scheper RJ, Flena MJ, Gariboldi MB and Monti E: Characterization of a clonal human colon adenocarcinoma line intrinsically resistant to doxorubicin. Br J Cancer 76: 67-76, 1997. (Pubitemid 27250078)
15. Molinari A, Calcabrini A, Crateri P and Arancia G: Interaction of anthracycline antibiotics with cytoskeletal components of cultured carcinoma cells (CG5). Exp Mol Pathol 53: 11-33, 1990. (Pubitemid 20303147)
16. Duranton B, Holl V, Schneider Y, Carnesecchi S, Gosse F, Raul F and Seiler N: Cytotoxic effects of the polyamine oxidase inactivator MDL 72527 to two human colon carcinoma cell lines SW 480 and SW 629. Cell Biol Toxicol 18: 381-396, 2002. (Pubitemid 35396702)
17. Arancia G, Calcabrini A, Meschini S and Molinari A: Intracellular distribution of anthracycline in drug resistant cells. Cytotechnology 27: 95-111, 1998. (Pubitemid 29025463)
18. Gervasoni JE, Fields SZ, Krishna S, Baker MA, Rosado M, Thuraisami K, Hinderburg AA and Taub RN: Subcellular distribution of doxorubicin in P-glycoprotein positive and negative drug resistant cell lines using laser-assisted confocal microscopy. Cancer Res 51: 4955-4963, 1991.
19. Gottesman MM and Pastan I: Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu Rev Biochem 62: 385-427, 1993. (Pubitemid 23237876)
20. Demers N, Agostinelli E, Averill-Bates DA and Fortier G: Immobilization of native and poly(ethylene glycol)-treated ('PEGylated') bovine serum amine oxidase into a biocompatible hydrogel. Biotechnol Appl Biochem 33: 201-207, 2001.
21. Seiler N, Renault J, Gosse F, Roussi S and Raul F: Cytotoxicity of the polyamine oxidase inactivator MDL 72527 to cancer cells: comparison with a saturated structural analogue. Int J Oncol 27: 1669-1676, 2005.
22. Tagliabue G, Pifferi A, Balconi G, Mascellari E, Geroni C, D'Incalci M and Ubezio P: Intracellular glutathione heterogeneity in L1210 murine leukemia sublines made resistant to DNA-interacting antineoplastic agents. Int J Cancer 54: 435-442, 1993.
23. Chau YP, Shiah SG, Don MJ and Kuo ML: Involvement of hydrogen peroxide in topoisomerase inhibitor β-lapachone-induced apoptosis and differentiation of human leukaemia cells. Free Radic Biol Med 24: 660-670, 1998.
24. Porter CW, Stanek J, Black J, Vaughan M, Ganis B and Pleshkewych A: Morphological evidence for an apparent lysosomotropic activity by unsaturated putrescine analogues. Cancer Res 50: 1929-1935, 1990.
25. Greenberger JS, Kagan VE, Pearce L, Boriseniao G, Tyurina Y and Epperli MW: Modulation of redox signal transduction pathways in the treatment of cancer. Antioxid Redox Signal 3: 347-359, 2001.
26. Houen G, Bock K and Jensen AL: HPLC and NMR investigation of the serum amine oxidase-catalyzed reaction of polyamines. Acta Chem Scand 48: 52-60, 1994.
27. Zhao M, Antunes F, Eaton JW and Brunk UT: Lysosomal enzymes promote mitochondrial oxidant production, cytochrome c release and apoptosis. Eur J Biochem 270: 13778-13786, 2003.
28. Yu Z, Li W and Brunk UT: 3-Aminopropanal is a lysosomotropic aldehyde that causes oxidative stress and apoptosis by rupturing lysosomes. APMIS 111: 643-652, 2003.
29. Guicciardi ME, Leist M and Gores GJ: Lysosomes in cell death. Oncogene 23: 2881-2890, 2004.
30. 2-mediated damage to lysosomal membranes of J-774 cells. Free Rad Res Commun 18: 171-185, 1993.
31. Fehrenbacher N and Jaattela M: Lysosomes as targets for cancer therapy. Cancer Res 103: 1551-1560, 2005.